U.S.      SECURITIES AND EXCHANGE      COMMISSION

| (Mark                One)                                                                                                                        |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| [X]                                                                                                                                              | QUARTERLY                REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES                EXCHANGE ACT OF 1934 |
|                                                                                                                                             |   |   |
| For                the quarterly period ended July 31, 2007                                                                                      |
|                                                                                                                                             |   |   |
| [   ]                                                                                                                             | TRANSITION                REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES                EXCHANGE ACT OF 1934 |
|                                                                                                                                             |   |   |
|                   For                the transition period from ______to                ____        |
|                                                                                                                                        |
|  Commission                file number  000-51574                                                                                 |
|                                                                                                                                             |   |   |

**Med-Tech      Solutions, Inc.**

| **Nevada**                                                                                              | **98-0442163**                                      |
|---------------------------------------------------------------------------------------------------------|-----------------------------------------------------|
| (State                or other jurisdiction of incorporation                or organization)            | (I.R.S.                Employer Identification No.) |
|                                                                                                    |                                                |
| Suite                2200 - 1177 West Hastings StreetVancouver,                British Columbia, Canada |  V6E                2K3                        |
| (Address                of principal executive offices)                                                 | (Zip                Code)                           |
|                                                                                                    |                                                |

----

**MED-TECH      SOLUTIONS, INC.**

**INDEX**

| **PART                  I – FINANCIAL INFORMATION:**  |                                                                                                                                                                                                                                                                                          |  Page |
|------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| Item                  1.                                         | Condensed                  Financial Statements                                                                                                                                                                                                                                               |       | 1 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
|                                                             | Condensed                  Balance Sheets at July 31, 2007 (unaudited) and October 31,                  2007                                                                                                                                                                                  |       | 2 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
|                                                             | Condensed                  Statements of Operations for the Three and Nine Months Ended July                  31, 2007                  and 2006 (unaudited), and for the Cumulative Period from May 28,                  2004                  (Inception) through July 31, 2007 (unaudited) |       |                  3 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
|                                                             | Condensed                  Statement of Changes in Stockholders’ (Deficiency) Equity for                  the Period from Inception,  May 28, 2004 to July 31, 2007                  unaudited)                                                                          |       | 4 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
|                                                             | Condensed                    Statements of Cash Flows for the Nine Months Ended July 31, 2007                    and 2006                    (unaudited), and for the Cumulative Period from  May 28, 2004                    (Inception) through July 31, 2007 (unaudited)              |       | 5 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
|                                                             | Notes                  to Condensed Financial Statements (unaudited)                                                                                                                                                                                                                          |       | 6 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| Item                  2.                                         | Management’s                  Discussion and Analysis of Financial Condition and Results                  of Operations                                                                                                                                                                 |       | 13 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| Item                  3.                                         | Controls                  and Procedures                                                                                                                                                                                                                                                      |       | 19 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| **PART                  II – OTHER INFORMATION:**     |                                                                                                                                                                                                                                                                                          |       |
|                                                             |                                                                                                                                                                                                                                                                                          |       |
| Item                  1.                                         | Legal                  Proceedings                                                                                                                                                                                                                                                            |       | 19 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| Item                  2.                                         | Unregistered                  Sales of Equity Securities and Use of Proceeds                                                                                                                                                                                                                  |       | 19 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| Item                  3.                                         | Defaults                  Upon Senior Securities                                                                                                                                                                                                                                              |       | 19 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| Item                  4.                                         | Submission                  of Matters to a Vote of Security Holders                                                                                                                                                                                                                          |       | 19 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| Item                  5.                                         | Other                  Information                                                                                                                                                                                                                                                            |       | 19 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| Item                  6.                                         | Exhibits                                                                                                                                                                                                                                                                                      |       | 19 |
|                                                             |                                                                                                                                                                                                                                                                                          |       |   |
| Signatures                                                       |                                                                                                                                                                                                                                                                                          |       | 20 |

----

**PART      I – FINANCIAL INFORMATION**

| **Item                1.** | **Financial                Statements.** |
|----------------------------|------------------------------------------|

----

**MED-TECH        SOLUTIONS, INC.**

**(A          Development Stage Enterprise)**

**UNAUDITED          CONDENSED BALANCE SHEET**

**(Stated          in US Dollars)**

|                                                                                                                                                                                                                                        |   | (Unaudited)              |      |   |                        |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------|-----------|--------|-----------------------------|--------|
|                                                                                                                                                                                                                                        |   | July                  31 |      |   | October                  31 |   |
|                                                                                                                                                                                                                                        |   | 2007                     |      |   | 2006                        |   |
| ASSETS                                                                                                                                                                                                                                      |   |                     |      |   |                        |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |
| CURRENT                  ASSETS                                                                                                                                                                                                             |   |                     |      |   |                        |   |
| Cash                                                                                                                                                                                                                                        |   | $                        | 27,796    |   |                        | $      | 3,112 |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| LONG                  TERM                                                                                                                                                                                                                  |   |                     |      |   |                        |   |   |   |
| Investments                  (Note 3)                                                                                                                                                                                                       |   |                     | 2,080,000 |   |                        |   | - |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| Total                  assets                                                                                                                                                                                                               |   | $                        | 2,107,796 |   |                        | $      | 3,112 |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| LIABILITIES                  AND STOCKHOLDERS'  EQUITY/(DEFICIENCY)                                                                                                                                                               |   |                     |      |   |                        |   |   |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| CURRENT                  LIABILITIES                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| Accounts                  payable and accrued liabilities                                                                                                                                                                                   |   | $                        | 40,545    |   |                        | $      | 15,000 |   |
| Due                  to director (Note 4)                                                                                                                                                                                                   |   |                     | 4,231     |   |                        |   | 21,200 |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
|                                                                                                                                                                                                                                        |   |                     | 44,776    |   |                        |   | 36,200 |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| Commitments                  and contingencies (Note 7)                                                                                                                                                                                     |   |                     |      |   |                        |   |   |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| STOCKHOLDERS'                  EQUITY/(DEFICIENCY) (Note 6)                                                                                                                                                                                 |   |                     |      |   |                        |   |   |   |
| Preferred                  shares; par value $0.001 per share; 100,000,000 shares authorized,                  -0- and                  -0- issued and outstanding as of July 31, 2007 and October 31,                  2006                |   |                     | -         |   |                        |   | - |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| Common                  stock; par value $0.001 per share; 500,000,000 shares authorized,and                  106,737,375 and 101,000,000 issued and outstanding as of July 31,                  2007 and                  October 31, 2006 |   |                     | 106,738   |   |                        |   | 101,000 |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| Additional                  paid in capital                                                                                                                                                                                                 |   |                     | 2,293,024 |   |                        |   | 4,000 |   |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| Deficit                  accumulated during development stage                                                                                                                                                                               |   |                     | (336,742  | )      |                        |   | (138,088 | ) |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| Stockholders'                  equity/(deficiency)                                                                                                                                                                                          |   |                     | 2,063,020 |   |                        |   | (33,088 | ) |
|                                                                                                                                                                                                                                        |   |                     |      |   |                        |   |   |   |
| Total                  liabilities and stockholders' equity/(deficiency)                                                                                                                                                                    |   | $                        | 2,107,796 |   |                        | $      | 3,112 |   |

----

**MED-TECH        SOLUTIONS, INC**

**(A        Development Stage Enterprise)**

**UNAUDITED        CONDENSED STATEMENT OF OPERATIONS**

**(Stated        in US Dollars)**

**(unaudited)**

|                                                  |   | for                  the period      |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |
|-------------------------------------------------------|--------|--------------------------------------|----------|-------------|---------------------------------------------|--------|----------|--------------------------------------------|--------|--------|--------------------------|-------------|--------|--------------------------|----------|
|                                                  |   | May                  28, 2004        |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |
|                                                  |   | (date                  of inception) |     |        |                                        |   |     |                                       |   |   |                     |        |
|                                                  |   | through                              |     |        | for                  the three months ended |   |     | for                  the nine months ended |   |
|                                                  |   | July                  31             |     |        | July                  31                    |   |     | July                  31                   |   |   | July                  31 |        |   | July                  31 |     |
|                                                  |   | 2007                                 |     |        | 2007                                        |   |     | 2006                                       |   |   | 2007                     |        |   | 2006                     |     |
|                                                  |   |                                 |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |
|                                                  |   |                                 |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |
| OPERATING                  EXPENSES                   |   | $                                    | 336,742  |        |                                        | $      | 112,149  |                                       |   | $      | 15,530                   |        |   | $                        | 198,654  |   |   | $ | 32,787 |   |
|                                                  |   |                                 |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |   |   |   |   |   |
| LOSS                  FROM OPERATIONS                 |   |                                 | (336,742 | )           |                                        |   | (112,149 | )                                          |   |   | (15,530                  | )           |   |                     | (198,654 | ) |   |   | (32,787 | ) |
|                                                  |   |                                 |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |   |   |   |   |   |
| INCOME                  TAXES                         |   |                                 | -        |        |                                        |   | -        |                                       |   |   | -                        |        |   |                     | -        |   |   |   | - |   |
|                                                  |   |                                 |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |   |   |   |   |   |
| NET                  LOSS FOR THE PERIOD              |   | $                                    | (336,742 | )           |                                        | $      | (112,149 | )                                          |   | $      | (15,530                  | )           |   | $                        | (198,654 | ) |   | $ | (32,787 | ) |
|                                                  |   |                                 |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |   |   |   |   |   |
|                                                  |   |                                 |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |   |   |   |   |   |
| BASIC                  AND DILUTED LOSS PER SHARE     |   |                                 |     |        |                                        | $      | (0.001   | )                                          |   | $      | (0.002                   | )           |   | $                        | (0.002   | ) |   | $ | (0.003 | ) |
|                                                  |   |                                 |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |   |   |   |   |   |
| WEIGHTED                  AVERAGE NUMBER OF BASIC AND |   |                                 |     |        |                                        |   |     |                                       |   |   |                     |        |   |                     |     |   |   |
| DILUTED                  COMMON SHARES OUTSTANDING    |   |                                 |     | 106,737,375 |                                        |   |     | 10,100,000                                 |   |   |                     | 103,549,944 |   |                     |     | 10,100,000 |   |

----

**MED-TECH          SOLUTIONS, INC.**

**(A          Development Stage Enterprise)**

**STATEMENT          OF STOCKHOLDERS' (DEFICIENCY) EQUITY**

**FOR            THE PERIOD FROM INCEPTION, MAY 28, 2004 TO JULY 31,            2007**

**(Stated            in US Dollars)**

**(unaudited)**

|                                                         |   | (Note                    6)        |        |   |                         |   |    |                       |   |   | Deficit                       |   |   |          |     |
|--------------------------------------------------------------|--------|------------------------------------|-------------|--------|------------------------------|--------|---------|----------------------------|--------|--------|-------------------------------|--------|--------|---------------|----------|
|                                                         |   | Common                             |        |   |                         |   |    |                       |   |   | Accumulated                   |   |   |  Total   |     |
|                                                         |   | Shares                             |        |   |                         |   |    | Additional                 |   |   | During                    the |   |   | Stockholders' |     |
|                                                         |   | Number                             |        |   |                         |   |    | Paid                    In |   |   | Develoment                    |   |   | Equity/       |     |
|                                                         |   | of                     Shares |        |   | Par                    Value |   |    | Capital                    |   |   | Stage                         |   |   | (Deficiency)  |     |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |
| May                    2004, issued common                   |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |
|   shares                    for cash $0.0001       |   |                               | 50,000,000  |   |                         | $      | 50,000  |                       |   | $      | (45,000                       | )      |   | $             | -        |   |   | $ | 5,000 |   |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| September                    2004, issued common             |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
|   shares                    for cash @ $0.001      |   |                               | 50,000,000  |   |                         |   | 50,000  |                       |   |   | -                             |   |   |          | -        |   |   |   | 50,000 |   |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| Net                    loss for the period ended             |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
|    October                    31, 2004        |   |                               | -           |   |                         |   | -       |                       |   |   | -                             |   |   |          | (9,076   | ) |   |   | (9,076 | ) |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| Balance,                    October 31, 2004                 |   |                               | 100,000,000 |   |                         |   | 100,000 |                       |   |   | (45,000                       | )      |   |          | (9,076   | ) |   |   | 45,924 |   |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| November                    2004,  issued common   |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
|    shares                    for cash @ $0.05 |   |                               | 1,000,000   |   |                         |   | 1,000   |                       |   |   | 49,000                        |   |   |          | -        |   |   |   | 50,000 |   |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| Net                    loss for the year ended               |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
|   October                    31, 2005              |   |                               | -           |   |                         |   | -       |                       |   |   | -                             |   |   |          | (71,086  | ) |   |   | (71,086 | ) |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| Balance,                    October 31, 2005                 |   |                               | 101,000,000 |   |                         |   | 101,000 |                       |   |   | 4,000                         |   |   |          | (80,162  | ) |   |   | 24,838 |   |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| Net                    loss for the year ended               |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
|   October                    31, 2006              |   |                               | -           |   |                         |   | -       |                       |   |   | -                             |   |   |          | (57,926  | ) |   |   | (57,926 | ) |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| Balance,                    October 31, 2006                 |   |                               | 101,000,000 |   |                         |   | 101,000 |                       |   |   | 4,000                         |   |   |          | (138,088 | ) |   |   | (33,088 | ) |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| March                    2007, issued common                 |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
|    shares                    for cash @ $0.40 |   |                               | 5,737,375   |   |                         |   | 5,738   |                       |   |   | 2,289,024                     |   |   |          | -        |   |   |   | 2,294,762 |   |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| Net                    loss for the period ended             |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
|   July                    31, 2007                 |   |                               | -           |   |                         |   | -       |                       |   |   | -                             |   |   |          | (198,654 | ) |   |   | (198,654 | ) |
|                                                         |   |                               |        |   |                         |   |    |                       |   |   |                          |   |   |          |     |   |   |   |   |   |
| Balance,                    July 31, 2007                    |   |                               | 106,737,375 |   |                         | $      | 106,738 |                       |   | $      | 2,293,024                     |   |   | $             | (336,742 | ) |   | $ | 2,063,020 |   |

----

**MED-TECH        SOLUTIONS, INC.**

**(A        Develoment Stage Enterprise)**

**UNAUDITED        CONDENSED STATEMENT OF CASH FLOWS**

**(Stated        in US Dollars)**

**(unaudited)**

|                                                                         |   | for                  the period      |       |   |                                       |   |       |                     |   |
|------------------------------------------------------------------------------|--------|--------------------------------------|------------|--------|--------------------------------------------|--------|------------|--------------------------|--------|
|                                                                         |   | May                  28, 2004        |       |   |                                       |   |       |                     |   |
|                                                                         |   | (date                  of inception) |       |   |                                       |   |
|                                                                         |   | through                              |       |   | for                  the nine months ended |   |
|                                                                         |   | July                  31             |       |   | July                  31                   |   |       | July                  31 |   |
|                                                                         |   | 2007                                 |       |   | 2007                                       |   |       | 2006                     |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |
| OPERATING                  ACTIVITIES                                        |   |                                 |       |   |                                       |   |       |                     |   |
| Net                  loss for the period                                     |   | $                                    | (336,742   | )      |                                       | $      | (198,654   | )                        |   | $ | (32,787 | ) |
| Item                  not affecting cash                                     |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
|                      Amortization of license agreement        |   |                                 | 165        |   |                                       |   | -          |                     |   |   | 123 |   |
|                      Write off of license agreement           |   |                                 | 8,065      |   |                                       |   | -          |                     |   |   | - |   |
| Changes                  in non-cash working capital items                   |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
|                      Accounts payable and accrued liabilities |   |                                 | 40,545     |   |                                       |   | 25,545     |                     |   |   | 9,842 |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| Cash                  used by operating activities                           |   |                                 | (287,967   | )      |                                       |   | (173,109   | )                        |   |   | (22,822 | ) |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| FINANCING                  ACTIVITIES                                        |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| Advance                  from shareholders                                   |   |                                 | 4,231      |   |                                       |   | (16,969    | )                        |   |   | (3,200 | ) |
| Issuance                  of share capital                                   |   |                                 | 2,399,762  |   |                                       |   | 2,294,762  |                     |   |   | - |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| Cash                  provided by/(used) for financing activities            |   |                                 | 2,403,993  |   |                                       |   | 2,277,793  |                     |   |   | (3,200 | ) |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| INVESTING                  ACTIVITIES                                        |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| Investment                  acquired                                         |   |                                 | (2,080,000 | )      |                                       |   | (2,080,000 | )                        |   |   | - |   |
| Acquisition                  of license agreement                            |   |                                 | (8,230     | )      |                                       |   | -          |                     |   |   | - |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| Cash                  used by investing activities                           |   |                                 | (2,088,230 | )      |                                       |   | (2,080,000 | )                        |   |   | - |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| CASH                  INCREASE/(DECREASE)                                    |   |                                 | 27,796     |   |                                       |   | 24,684     |                     |   |   | (26,022 | ) |
| CASH,                  BEGINNING OF PERIOD                                   |   |                                 | -          |   |                                       |   | 3,112      |                     |   |   | 26,553 |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| CASH,                  END OF PERIOD                                         |   | $                                    | 27,796     |   |                                       | $      | 27,796     |                     |   | $ | 531 |   |
|                                                                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| SUPPLEMENTAL                  CASH FLOW INFORMATION:                         |   |                                 |       |   |                                       |   |       |                     |   |   |   |   |
| Interest                  paid                                               |   | $                                    | -          |   |                                       | $      | -          |                     |   | $ | - |   |
| Income                  taxes paid                                           |   | $                                    | -          |   |                                       | $      | -          |                     |   | $ | - |   |

----

**Med-Tech          Solutions, Inc.**

**(A          Development Stage Enterprise)**

**Notes          to the Condensed Financial Statements**

**(Expressed          in US Dollars)**

**(Unaudited)**

----

**July          31, 2007**

----

| **1.** | **Nature                  of Operations** |
|--------|-------------------------------------------|

----

**Med-Tech          Solutions, Inc.**

**(A          Development Stage Enterprise)**

**Notes          to the Condensed Financial Statements**

**(Expressed          in US Dollars)**

**(Unaudited)**

----

**July          31, 2007**

----

| **1.** | **Nature                  of Operations (continued)** |
|--------|-------------------------------------------------------|

| **2.  ** | **Significant                  Accounting Policies** |
|--------------------|------------------------------------------------------|

| ** a) ** | **                    Development stage company** |
|--------------------|-------------------------------------------------------------|

| **b) ** | **                    Foreign currency                  translation** |
|--------------|---------------------------------------------------------------------------------|

| **c) ** | **                    Basic and diluted loss per                  share** |
|--------------|-------------------------------------------------------------------------------------|

----

**Med-Tech          Solutions, Inc.**

**(A          Development Stage Enterprise)**

**Notes          to the Condensed Financial Statements**

**(Expressed          in US Dollars)**

**(Unaudited)**

----

**July          31, 2007**

----

| **2.** | **Significant                  Accounting Policies                  (continued)** |
|--------|-----------------------------------------------------------------------------------|

| **d)** | **                    Financial instruments** |
|--------|---------------------------------------------------------|

| **e)** | **                    Income taxes** |
|--------|------------------------------------------------|

|  | **f)** | **                    Cash and cash                  equivalents** |
|--|--------|------------------------------------------------------------------------------|

| **                                g)** | **                    Stock-Based Compensation** |
|--------------------------------------------------------------------------------------------------------------|------------------------------------------------------------|

*Share-Based Payment*
*Accounting for Stock Issued to Employees*

----

**Med-Tech          Solutions, Inc.**

**(A          Development Stage Enterprise)**

**Notes          to the Condensed Financial Statements**

**(Expressed          in US Dollars)**

**(Unaudited)**

----

**July          31, 2007**

----

| **3.  ** | **Significant                  Accounting Policies****(continued)** |
|--------------------|---------------------------------------------------------------------|

|  |  | **g)                     Stock-Based Compensation                  (continued)** |
|--|--|-------------------------------------------------------------------------------------------------|

|  | **h)** | **Revenue                  Recognition** |
|--|--------|------------------------------------------|

|  | **i)** | **Advertising                  Costs** |
|--|--------|----------------------------------------|

|  | **j)** | **Research                  and Development** |
|--|--------|-----------------------------------------------|

|  | **k)** | **Segment                  Information** |
|--|--------|------------------------------------------|

|  | **l)** | **Liquidity** |
|--|--------|---------------|

----

**Med-Tech          Solutions, Inc.**

**(A          Development Stage Enterprise)**

**Notes          to the Condensed Financial Statements**

**(Expressed          in US Dollars)**

**(Unaudited)**

----

**July          31, 2007**

----

**2.**
**Significant        Accounting Policies**
**(continued)**

| **                   m) ** | **                    Long Lived Assets** |
|--------------------------------------|-----------------------------------------------------|

| ** n) ** | **                    Debt and Equity Securities** |
|--------------------|--------------------------------------------------------------|

| **3.** | **Investment** |
|--------|----------------|

----

**Med-Tech          Solutions, Inc.**

**(A          Development Stage Enterprise)**

**Notes          to the Condensed Financial Statements**

**(Expressed          in US Dollars)**

**(Unaudited)**

----

**July        31, 2007**

----

**3.         Investment        (continued)**

| **4.  ** | **                    Related Party Transactions** |
|--------------------|--------------------------------------------------------------|

|   | **a)** | During                  fiscal 2004, the President and Sole Director of the Company paid                  expenses                  on behalf of the Company.  This advance was repaid during fiscal                  2005.  Since inception the President and Sole Director of the                  Company has invoiced the Company for rent in the amount of $5,000 ($12,300                  paid). The balance is non-interest bearing, unsecured and due on                  demand.  During fiscal 2006, the President and Sole Director of                  the Company advanced an additional loan of $25,530 on the same                  terms of                  which $4,231 was outstanding at July 31,                  2007. |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | **b)** | During                  fiscal 2004 the President and Sole Director of the Company purchased                  5,000,000 common shares from treasury for cash of                  $5,000. |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **5.** | **License                  Agreement** |
|--------|----------------------------------------|

| **6.** | **Share                  Capital** |
|--------|------------------------------------|

----

**Med-Tech          Solutions, Inc.**

**(A          Development Stage Enterprise)**

**Notes          to the Condensed Financial Statements**

**(Expressed          in US Dollars)**

**(Unaudited)**

----

**July          31, 2007**

----

| **6.** |   | ** Share                  Capital (continued)** |
|--------|--------|------------------------------------------------------|

|   | In                  May 2004, the Company issued 50,000,000 common shares at $0.0001                  per share                  for gross proceeds of $5,000. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | In                  November 2004, the Company issued 1,000,000 common shares at $0.05                  per                  share for gross proceeds of                  $50,000. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | In                  March 2007, the Company issued 5,737,500 common shares at $0.40                  per share                  for gross proceeds of $2,294,762. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **7.** | **Commitments                  and contingencies** |
|--------|----------------------------------------------------|

----

| **Item                2.** | Management’s                  Discussion and                  Analysis of Financial Condition and Results of                  Operations. |
|----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|

**Risk      Factors**

**Introduction**

----

**Organizational      History**

**Recent      Developments**

----

**Plan      Of Operation**

----

| Category                           | Planned              Expenditures Over The Next Twelve Months |   |
|------------------------------------|---------------------------------------------------------------|--------|
| Professional              Fees (1) | $80,000              (1)                                      |   |
| Office              Expenses       | $5,000                                                        |   |
| Travel              Expenses (2)   | $5,000                                                        |   |
| TOTAL                              | $90,000                                                       |   |

----

**Results      Of Operations**

----

**Liquidity      And Capital      Resources**

**Off-Balance      Sheet Arrangements**

**Critical      Accounting Policies**

----

| **Item                3.** | **Controls                and Procedures.** |
|----------------------------|---------------------------------------------|

**PART      II — OTHER INFORMATION**

**Item      1.   Legal Proceedings. **

**Item      2.   Unregistered Sales of Equity Securities and Use of      Proceeds.**

**Item      3.   Defaults Upon Senior      Securities.**

**Item      4.   Submission of Matters      to a Vote of      Security Holders.**

**Item      5.   Other Information.**

**Item      6.   Exhibits.**

| **Exhibit** | **Description**                                                                                                                                                                                                                                                                                                                                    |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1        | Certification                of the Company’s Principal Executive Officer and Principal Financial                Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002,                with                respect to the registrant’s Quarterly Report on Form 10-QSB for the                quarter ended July 31, 2007. |
|        |                                                                                                                                                                                                                                                                                                                                               |
| 32.1        | Certification                of the Company’s Principal Executive Officer and Principal Financial                Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to                Section                906 of the Sarbanes Oxley Act of                2002.                                                              |

----

**SIGNATURES**

|                                         | MED-TECH                SOLUTIONS, INC. |                                                                                            |
|----------------------------------------------|-----------------------------------------|-------------------------------------------------------------------------------------------------|
|                                         |                                    |                                                                                            |   |
| Date:                September 18, 2007 | By:                                     | /s/ Mark              A. McLeary                                                           |   |
|                                         |                                    | Name: Mark              A.              McLeary                                            |   |
|                                         |                                    | Title:  Chief              Executive              Officer and Chief Financial Officer |   |
|                                         |                                    |                                                                                            |   |